Oncology PET
Westside Medical Imaging Are Proud Participants In The National Oncologic PET Registry
The National Oncologic PET Registry (NOPR) was developed in response to the Centers for Medicare and Medicaid Services (CMS) proposal to expand coverage for FDG-PET to include cancers and indications not presently eligible for Medicare reimbursement. This offers tremendous opportunity for demonstrating effective management of cancer patients and for the expansion of PET covered indications.
 Top Ten NOPR Cancer Sites
- Prostate
- Ovary and uterine adenexa
- Pancreas
- Bladder
- Kidney and other urinary tract
- Small-cell lung
- Stomach
- Non-small cell lung
- Uterus, body
- Liver and intrahepatic bile ducts
Top Ten NOPR Cancer Sites/Indications
- Ovary and uterine adenexa - Recurrence
- Prostate - Initial staging
- Prostate - Restaging
- Prostate - Recurrence
- Ovary and uterine adenexa - Restaging
- Ovary and uterine adenexa - Treatment monitoring
- Stomach - Initial staging
- Pancreas - Initial staging
- Bladder - Initial staging
- Pancreas - Suspected primary
PET Bone Scans
A PET scan with sodium fluoride F 18 injection (18F NaF)
is a nuclear imaging test that scans your entire skeletal system and produces high-resolution images of your bones.
These images are used to detect areas of abnormal bone growth associated with tumors.
Listed below are many potentially useful applications
of PET imaging by indication.
- Bladder Cancer
- Brain Tumor
- Hepatocellular Cancer
- Musculoskeletal Tumors
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Renal Cell Cancer
- Small Cell Lung Cancer
- Soft Tissue Sarcoma
- Stomach Cancer
- Testicular Cancer
- Unknown Primary
- Uterine Cancer
- Thyroid Cancer and Cervical Cancer Thyroid Cancer
- Cervical Cancer
|
NOPR Coverage for Evaluation of Treatment Response for:
- Non small cell lung cancer
- Esophageal Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Lymphoma
- Melanoma
|
All other cancers not listed: http://www.cancerpetregistry.org/indications.htm
- Staging lymph nodes
- Assessing response to treatment
- Evaluate suspected recurrence
- Identifying recurrent disease after surgery and radiation
Process For Ordering FDG NOPR PET Studies: Referring Physiciand request a NOPR PET study, ideally, completing the Pre-PET Form at the time of scheduling. Once the test is completed the referring Physician completes Post-PET Form , indicates his/her consent for use of the data by NOPR, and returns all completed forms to Westside Medical Imaging.
Learn more about the National Oncologic PET Registry (NOPR) by visiting their Web site: http://www.cancerpetregistry.org/clinicians.htm
|
